@CleoNetwork

Canadian Network for Learning Healthcare Systems and Cost-Effective ‘Omics Innovation (CLEO). #RegulatoryScienceLab

Joined December 2019
  • Tweets319
  • Following331
  • Followers236
11Media
New CLEO publication on the diagnostic odyssey and forced resilience. @DeanRegier @moehman @DeirdreWeymann @samTpollard
Genetics in Medicine@GIMJournalApr 16
Colonialism, systemic discrimination, and racism have introduced barriers for #Indigenous families in healthcare. These challenges require resilience, often hindering access to #genomic #sequencing and extending journey toward a diagnosis. bit.ly/42alnEg #HealthEquity
2
3
86
CLEO Network retweeted
JAMA+ AI@JAMAplusAI5 Oct 2025
FDA-cleared #AI medical devices often experience recalls shortly after clearance, particularly those without clinical validation and produced by publicly traded companies. ja.ma/4pUOnuq
2
5
247
nejm.org/doi/full/10.1056/NE…
2
3
218
From genetic epidemiology to public health genomics and precision public health: Looking back, looking ahead. Via @KargerPublisher karger.com/phg/article/28/1/…

From Genes to Public Health: The Journey Continues!

At the end of 2024, I retired from the Centers for Disease Control and Prevention (CDC) after a 40-year career in public health. For the past 26 years, I led the Office of Public Health Genomics...

karger.com
1
4
19
528
[1] The value of large-scale programmes in human genomics | @jbuchanan_ox @CelineLewis23 @annekeluc @LizOrmondroyd | nature.com/articles/s41431-0… [2/3] #healtheconomics

The value of large-scale programmes in human genomics

European Journal of Human Genetics - Large national genomic programmes have been created in many countries, including France, England and Germany, to advance the realisation of the potential...

nature.com
1
1
69
NEW PUBLICATIONS IN HEALTH ECONOMICS AND GENOMICS 08/04/25 Two publications over the past week. Link to blog: healtheconomicsandgenomics.c… #healtheconomics [1/3]

New publications in health economics and genomics 8th April 2025

Two publications over the past week: The value of large-scale programmes in human genomics | link The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature Review | link…

healtheconomicsandgenomics.com
1
3
2
183
🚨 MILESTONE ALERT: Network publishes landmark paper in Cancer Cell! 🚨 The paper highlights the Network’s history, objectives and key accomplishments, underscoring how this unprecedented national collaboration is accelerating precision oncology! More ▶️bit.ly/4jemiKn
1
15
5
25
4,341
Ultima Genomics is providing 3 Trillion FREE reads to the research community! We want researchers to know they can COUNT ON US to help keep their science moving forward. Apply: ultimagenomics.com/count-on-… #NGS #Funding #Research #SingleCell #WGS #Proteomics #Multiomics
3
9
775
🍁 Researcher profile: A Q&A with Dr. Dean Regier 🍁 In the latest edition of our researcher profile series, Dr. @DeanRegier discusses his research, how the Network can help improve cancer care in Canada and the enduring legacy of Terry Fox. Read now: marathonofhopecancercentres.…
3
5
189
[1] Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A Population-Level Real-World Target Trial Emulation | @emanuelkrebs @DeirdreWeymann @samTpollard @DeanRegier | ascopubs.org/doi/10.1200/PO-… [2/2] #healtheconomics

Clinical Effectiveness and Cost-Effectiveness of Multigene Panel Sequencing in Advanced Melanoma: A...

PURPOSETargeted therapy and immunotherapy promise improved survival in patients with advanced melanoma, yet the effectiveness and cost-effectiveness of multigene panel sequencing compared with...

ascopubs.org
3
2
96
CLEO lead @DeanRegier in an op-ed discussing the necessity of Canada to step up and be the leader in translational medicine given policy and sentiment shifts in America
The Vancouver Sun
@VancouverSun11 Mar 2025
Dean Regier: Canada must step up as the global leader in pandemic preparedness vancouversun.com/opinion/op-…
2
2
145
NEW PUBLICATIONS IN HEALTH ECONOMICS AND GENOMICS 04/02/25 Three publications over the past week. Link to blog: healtheconomicsandgenomics.c… #healtheconomics [1/4]

New publications in health economics and genomics 4th February 2025

Three publications over the past week: Health Professionals’ Preferences for Next-Generation Sequencing in the Diagnosis of Suspected Genetic Disorders in the Paediatric Population | link Gen…

healtheconomicsandgenomics.com
1
3
1
151
[1] Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework | @hadleyssmith @DeanRegier @IliasGoranitis @jbuchanan_ox @Marshall_HEcon | link.springer.com/article/10… [2/3] #healtheconomics
1
3
1
4
502
New publication with lots of great people, led by @hadleyssmith and @Marshall_HEcon, on how to incorporate preferences when modelling the cost-effectiveness of genomic interventions. link.springer.com/article/10… #healtheconomics
Economics & genomics@econ_genomics21 Jan 2025
Replying to @econ_genomics
[1] Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework | @hadleyssmith @DeanRegier @IliasGoranitis @jbuchanan_ox @Marshall_HEcon | link.springer.com/article/10… [2/3] #healtheconomics
3
7
382
CLEO Network retweeted
Steven Jones
@sjmjones18 Dec 2024
Congratulations to Dr. Marco Marra on his appointment to the Order of Canada. A trailblazer in genomics, uncovering cancer drivers, and advancing precision medicine has cemented Canada’s place at the forefront of global cancer research. gg.ca/en/media/news/2024/app…
2
5
20
869
CLEO Network retweeted
Steven Jones
@sjmjones6 Dec 2024
Congrats to Dr. Nadine Caron on induction into the Canadian Medical Hall of Fame. Your groundbreaking work in Indigenous health and oncology is transforming care, inspiring future leaders and making a profound difference for communities across Canada bcgsc.ca/news/nadine-caron-i…
1
5
313
CLEO Network retweeted
CDA-AMC@CDA_AMC29 Nov 2024
⚠️Call for Patient and Clinician Input⚠️ We are requesting input on polatuzumab vedotin (#Polivy) for large B-cell lymphoma (#LBCL). Deadline is December 6, 2024. cda-amc.ca/polatuzumab-vedot… #HTA
1
1
294
[6] Next-generation sequencing in oncology: challenges in economic evaluations | @DeirdreWeymann @DeanRegier | pubmed.ncbi.nlm.nih.gov/3909… [7/8] #healtheconomics

Next-generation sequencing in oncology: challenges in economic evaluations - PubMed

Adapting methodological approaches and developing life-cycle health technology assessment (HTA) guidance using RWE is crucial for implementing NGS in oncology. Healthcare systems, decision-makers,...

pubmed.ncbi.nlm.nih.gov
1
4
6
170
(1/2) We’re now less than 1yr out from the IHEA 2025 Congress in Bali, Indonesia! A quick reminder that abstract submissions will close earlier than usual on 19-Nov-24. @healtheconomics #IHEA #healtheconomics #genomics healtheconomics.org/congress…
2
10
6
660
Exciting day!! Our new #RegulatoryScienceLab paper proposing multiple imputation for addressing immortal time bias in #precisionmedicine studies just came out in #HSR: onlinelibrary.wiley.com/doi/… Huge thank you to my co-authors @emanuelkrebs & @DeanRegier

Health Services Research | AcademyHealth & HRET Journal | Wiley Online Library

Objective To compare theoretical strengths and limitations of common immortal time adjustment methods, propose a new approach using multiple imputation (MI), and provide practical guidance for...

onlinelibrary.wiley.com
1
5
9
447
Load more